Mutation of zebrafish dihydrolipoamide branched-chain transacylase E2 results in motor dysfunction and models maple syrup urine disease
SUMMARY Analysis of zebrafish mutants that demonstrate abnormal locomotive behavior can elucidate the molecular requirements for neural network function and provide new models of human disease. Here, we show that zebrafish quetschkommode (que) mutant larvae exhibit a progressive locomotor defect tha...
Saved in:
Main Authors: | Timo Friedrich (Author), Aaron M. Lambert (Author), Mark A. Masino (Author), Gerald B. Downes (Author) |
---|---|
Format: | Book |
Published: |
The Company of Biologists,
2012-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Maple syrup urine disease: new insights from a zebrafish model
by: Nathan B. Roberts
Published: (2012) -
Case report: NAFLD and maple syrup urine disease: Is there an interplay between branched-chain amino acids and fructose consumption?
by: Helena Moreira-Silva, et al.
Published: (2022) -
Maple Syrup Urine Disease and Cerebral Edema
by: J Gordon Millichap
Published: (1991) -
Menkes Maple Syrup Urine Disease: Treatment
by: J Gordon Millichap
Published: (1991) -
Intravenous branched-chain amino-acid-free solution for the treatment of metabolic decompensation episodes in Spanish pediatric patients with maple syrup urine disease
by: Paula Sánchez-Pintos, et al.
Published: (2022)